Breaking News Instant updates and real-time market news.

OVID

Ovid Therapeutics

$6.45

-0.23 (-3.44%)

16:10
09/04/18
09/04
16:10
09/04/18
16:10

Ovid Therapeutics CFO Yaron Werber leaving company

Ovid Therapeutics announced that Yaron Werber, M.D., Chief Business and Financial officer, will leave the company effective Friday, September 21. Werber joined Ovid as CFO in June 2015 after nearly 15 years of experience as a highly-ranked biotechnology research analyst at marquee Wall Street firms. Members of management and the company's existing finance team, including Tim Daly, Ovid's senior VP, finance and corporate controller, will assume the duties and responsibilities of Werber on an interim basis. Ovid has initiated a search process for the selection of a new CFO.

  • 05

    Sep

  • 07

    Sep

OVID Ovid Therapeutics
$6.45

-0.23 (-3.44%)

04/20/18
LTCO
04/20/18
INITIATION
Target $27
LTCO
Buy
Ovid Therapeutics initiated with a Buy at Ladenburg
Ladenburg analyst Michael Higgins initiated Ovid Therapeutics with a Buy and $27 price target.
05/18/18
PIPR
05/18/18
INITIATION
Target $20
PIPR
Overweight
Ovid Therapeutics assumed with an Overweight at Piper Jaffray
Piper Jaffray analyst Tyler Van Buren assumed coverage of Ovid Therapeutics with an Overweight rating and $20 price target. The company is enrolling genetically-defined orphan populations with preclinical models that have demonstrated encouraging results, Van Buren tells investors in a research note.
08/06/18
PIPR
08/06/18
NO CHANGE
Target $20
PIPR
Overweight
Ovid Therapeutics shares should recover from here, says Piper Jaffray
Piper Jaffray analyst Tyler Van Buren attributes Ovid Therapeutics' selloff to the lack of statistical significance on the domain-based endpoints in the Phase 2 STARS trial, but he believes the shares will recover from these levels as appreciation for the just-reported data grows and as the report of OV935 proof of concept dEE data near year-end approaches. The analyst, who thinks the dEE data has "exciting potential," keeps an Overweight rating and $20 price target on Ovid shares, which are down 35% to $6.20 in afternoon trading.
08/10/18
PIPR
08/10/18
NO CHANGE
Target $20
PIPR
Overweight
Piper sees value coming back into Ovid shares after pullback
Shares of Ovid Therapeutics have pulled back following the recent Angelman's data release, but investors underappreciate the exploratory nature of what was the first study of its kind, Piper Jaffray analyst Tyler Van Buren tells investors in a research note. Further, he believes the FDA will give flexibility in designing a registrational program for OV101 given the lack of treatments option and the significant unmet needs that exists for these patients. The analyst maintains an Overweight rating on Ovid with a $20 price target, believing share value will accrue as investors get a greater appreciation for the OV101 program and opportunity.

TODAY'S FREE FLY STORIES

WMT

Walmart

$99.59

1.32 (1.34%)

14:10
03/18/19
03/18
14:10
03/18/19
14:10
Options
Walmart calls lead puts 3:1 and implied volatility is at 52-week lows »

Walmart calls lead puts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

  • 16

    May

14:10
03/18/19
03/18
14:10
03/18/19
14:10
General news
Oil Action: WTI crude »

Oil Action: WTI crude…

RCII

Rent-A-Center

$21.29

-0.0697 (-0.33%)

14:07
03/18/19
03/18
14:07
03/18/19
14:07
Hot Stocks
LMR Partners reports 7.02% passive stake in Rent-A-Center »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Apr

SKX

Skechers

$32.80

0.22 (0.68%)

14:05
03/18/19
03/18
14:05
03/18/19
14:05
Options
Skechers call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:05
03/18/19
03/18
14:05
03/18/19
14:05
General news
Fed funds futures are little changed, though deferred contracts are fractionally lower »

Fed funds futures are…

SNE

Sony

$46.06

-0.195 (-0.42%)

, EA

Electronic Arts

$98.17

-0.82 (-0.83%)

14:03
03/18/19
03/18
14:03
03/18/19
14:03
Hot Stocks
Sony Playstation, EA announce first season of Apex Legends starts March 19 »

Sony (SNE) Playstation…

SNE

Sony

$46.06

-0.195 (-0.42%)

EA

Electronic Arts

$98.17

-0.82 (-0.83%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GEVO

Gevo

$2.40

0.11 (4.80%)

14:03
03/18/19
03/18
14:03
03/18/19
14:03
Hot Stocks
Gevo calls out mention of company by Richard Branson »

Gevo's official…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

FLIR

Flir Systems

$49.83

-0.31 (-0.62%)

13:53
03/18/19
03/18
13:53
03/18/19
13:53
Downgrade
Flir Systems rating change  »

Flir Systems downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Apr

RIO

Rio Tinto

$57.03

1.04 (1.86%)

13:49
03/18/19
03/18
13:49
03/18/19
13:49
Periodicals
SEC can pursue Rio Tinto fraud cause, judge says, Reuters reports »

U.S. District Judge…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CREE

Cree

$56.77

-0.14 (-0.25%)

13:45
03/18/19
03/18
13:45
03/18/19
13:45
Options
Cree call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

ON

ON Semiconductor

$21.95

-0.23 (-1.04%)

13:39
03/18/19
03/18
13:39
03/18/19
13:39
Hot Stocks
ON Semiconductor has introduced two new silicon carbide, SiC Mosfet devices »

ON Semiconductor has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOG

Alphabet

$1,180.85

-4.41 (-0.37%)

, GOOGL

Alphabet Class A

$1,184.84

-6.94 (-0.58%)

13:38
03/18/19
03/18
13:38
03/18/19
13:38
Periodicals
Google denies working with Chinese military, NBCNews reports »

Google denied…

GOOG

Alphabet

$1,180.85

-4.41 (-0.37%)

GOOGL

Alphabet Class A

$1,184.84

-6.94 (-0.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

  • 27

    Mar

  • 04

    Apr

  • 27

    Oct

13:35
03/18/19
03/18
13:35
03/18/19
13:35
General news
U.S. corporate bond update: a couple of issuers are jumping in »

U.S. corporate bond…

CCI

Crown Castle

$124.05

-1.03 (-0.82%)

13:35
03/18/19
03/18
13:35
03/18/19
13:35
Options
Crown Castle put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:35
03/18/19
03/18
13:35
03/18/19
13:35
General news
Treasury Option Action: call spread liquidation »

Treasury Option Action:…

FB

Facebook

$159.31

-6.68 (-4.02%)

13:33
03/18/19
03/18
13:33
03/18/19
13:33
Periodicals
Blumenthal wants Facebook probe after live stream of mosque attack, NY Post says »

Senator Richard…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

  • 04

    Apr

DJX

Dow Jones Industrial Average

$0.00

(0.00%)

, SPX

S&P 500

$0.00

(0.00%)

13:30
03/18/19
03/18
13:30
03/18/19
13:30
Periodicals
U.K. speaker says parliament won't vote again on Brexit deal, WSJ reports »

John Bercow, speaker of…

DJX

Dow Jones Industrial Average

$0.00

(0.00%)

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$281.92

0.61 (0.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GNL

Global Net Lease

$18.38

-0.1 (-0.54%)

13:29
03/18/19
03/18
13:29
03/18/19
13:29
Conference/Events
Global Net Lease management to meet with JMP Securities »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 27

    Mar

  • 28

    Mar

  • 15

    Apr

NVRO

Nevro

$44.31

0.56 (1.28%)

13:27
03/18/19
03/18
13:27
03/18/19
13:27
Conference/Events
Nevro management to meet with JMP Securities »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 21

    Mar

NVRO

Nevro

$44.15

0.4 (0.91%)

13:27
03/18/19
03/18
13:27
03/18/19
13:27
Conference/Events
Nevro management to meet with SVB Leerink »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 21

    Mar

APYX

Apyx Medical

$7.93

0.005 (0.06%)

13:25
03/18/19
03/18
13:25
03/18/19
13:25
Conference/Events
Apyx Medical management to meet with JMP Securities »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Mar

T

AT&T

$30.77

0.09 (0.29%)

13:24
03/18/19
03/18
13:24
03/18/19
13:24
Periodicals
Kevin Tsujihara ousted as Warner Bros. CEO, CNBC reports »

Kevin Tsujihara has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 20

    Mar

  • 24

    Apr

  • 26

    Apr

  • 20

    May

CXP

Columbia Property

$21.99

-0.13 (-0.59%)

13:21
03/18/19
03/18
13:21
03/18/19
13:21
Conference/Events
Columbia Property management to meet with JMP Securities »

Meeting to be held in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

BSX

Boston Scientific

$37.77

-2.38 (-5.93%)

13:20
03/18/19
03/18
13:20
03/18/19
13:20
Options
Quarter million dollar block of calls sold to open in Boston Scientific »

Quarter million dollar…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    May

  • 28

    May

MIK

Michaels

$11.72

0.04 (0.34%)

, DSW

DSW

$25.05

-0.34 (-1.34%)

13:19
03/18/19
03/18
13:19
03/18/19
13:19
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

MIK

Michaels

$11.72

0.04 (0.34%)

DSW

DSW

$25.05

-0.34 (-1.34%)

HDS

HD Supply

$42.88

-0.12 (-0.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 19

    Mar

  • 19

    Mar

  • 25

    Mar

  • 26

    Mar

  • 27

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.